These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3033699)

  • 1. Differential biochemical mechanisms mediate locomotor stimulation effects by caffeine and nicotine in rats.
    Lee EH; Tsai MJ; Tang YP; Chai CY
    Pharmacol Biochem Behav; 1987 Feb; 26(2):427-30. PubMed ID: 3033699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicotine, caffeine, and their combination on locomotor activity in rats.
    Cohen C; Welzl H; Bättig K
    Pharmacol Biochem Behav; 1991 Sep; 40(1):121-3. PubMed ID: 1780334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine and nicotine: differential effects on ambulation, rearing and wheelrunning.
    Meliska CJ; Loke WH
    Pharmacol Biochem Behav; 1984 Dec; 21(6):871-5. PubMed ID: 6522417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic caffeine consumption on changes in locomotor activity of WAG/G and Fischer-344 rats induced by nicotine, ethanol, and morphine.
    Sudakov SK; Rusakova IV; Medvedeva OF
    Bull Exp Biol Med; 2003 Dec; 136(6):563-5. PubMed ID: 15500072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of caffeine and nicotine on avoidance learning in mice: lack of interaction.
    Sansone M; Battaglia M; Castellano C
    J Pharm Pharmacol; 1994 Sep; 46(9):765-7. PubMed ID: 7837048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the behavioral effects of nicotine by chronic caffeine exposure.
    Tanda G; Goldberg SR
    Pharmacol Biochem Behav; 2000 May; 66(1):47-64. PubMed ID: 10837843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine induced behavioral locomotor sensitization.
    Domino EF
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jan; 25(1):59-71. PubMed ID: 11263759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance.
    de Bartolomeis A; Iasevoli F; Marmo F; Buonaguro EF; Avvisati L; Latte G; Tomasetti C
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):538-559. PubMed ID: 29475793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the interaction between caffeine and barbiturates with respect to locomotor activity and brain catecholamines.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):172-80. PubMed ID: 1173516
    [No Abstract]   [Full Text] [Related]  

  • 10. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
    Celik E; Uzbay IT; Karakas S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
    Sawynok J; Reid A
    J Pharmacol Exp Ther; 1996 May; 277(2):646-53. PubMed ID: 8627541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of caffeine and nicotine on open-field exploration.
    Loke WH; Meliska CJ
    Psychol Rep; 1984 Oct; 55(2):447-51. PubMed ID: 6514920
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
    Strömberg U; Waldeck B
    J Neural Transm; 1973; 34(4):241-52. PubMed ID: 4359657
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
    Clarke PB; Fu DS; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1988 Aug; 246(2):701-8. PubMed ID: 3136244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.
    Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K
    Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of nicotine on locomotor activity and dopamine overflow in the alcohol-preferring AA and alcohol-avoiding ANA rats.
    Kiianmaa K; Tuomainen P; Makova N; Seppä T; Mikkola JA; Petteri Piepponen T; Ahtee L; Hyytiä P
    Eur J Pharmacol; 2000 Nov; 407(3):293-302. PubMed ID: 11068025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization.
    Fredrickson P; Boules M; Yerbury S; Richelson E
    Brain Res; 2003 Jul; 979(1-2):245-8. PubMed ID: 12850594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
    Vezina P; Blanc G; Glowinski J; Tassin JP
    J Pharmacol Exp Ther; 1992 May; 261(2):484-90. PubMed ID: 1578364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose.
    Gasior M; Jaszyna M; Peters J; Goldberg SR
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1101-11. PubMed ID: 11082446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.